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Endothelial cells inhibit blood platelets by releasing
nitric oxide (NO) and prostacyclin (PGI2). NO and
PGI2 activate cGMP and cAMP synthesis, leading to the
activation of cGMP- and cAMP-dependent protein
kinases (PKG, PKA), phosphorylation of substrate pro-
teins, and inhibition and reversal of platelet activation
and aggregation. A known target of PKA and PKG is
the small G-protein Rac1. The active form of Rac1,
Rac1-GTP, contributes to cytoskeletal reorganization,
platelet spreading, adhesion, granule release, and aggre-
gation. PKG and PKA activation have been shown to
reduce Rac1-GTP levels. Rac1-GTP is controlled by
GTPase-activating proteins (GAPs - reduce Rac1-GTP)
and Guanine-nucleotide exchange factors (GEFs - elevate
Rac1-GTP). We hypothesized that specific GAPs and/or
GEFs might mediate the inhibitory effects of PKG and
PKA on Rac1. Screening for potential substrates among
the GAPs and GEFs expressed in platelets resulted in the
identification of the GAP ARHGAP17 (also known as
Rich1 or Nadrin) as well as the GEF ARHGEF6 (also
known as alpha-PIX or Cool2) as new substrates of PKG
and PKA in human platelets. We mapped the phosphory-
lation sites on ARHGAP17 and ARHGEF6, and we inves-
tigated the functional consequences of phosphorylation.
Phosphorylation of ARHGAP17 by PKA resulted in a dis-
sociation of ARHGAP17 and its interaction partner CIP4.
Phosphorylation of ARHGEF6 by both kinases resulted in
the association of the ARHGEF6/GIT1 complex with the
phospho-serine/threonine binding protein 14-3-3.
Our data suggest that PKG- and PKA-mediated phos-
phorylations of ARHGAP17 and ARHGEF6 lead to a reor-
ganization of protein complexes involved in the control of
Rac1. These events are likely to contribute to Rac1 inhibi-
tion by cyclic nucleotides. Similar findings regarding the
regulation of a critical small G-protein by GAP and GEF
phosphorylation have been described for Rap1 in platelets
before. We conclude that phosphorylation of GAPs and
GEFs of small G-proteins might represent a general princi-
ple of platelet regulation by cGMP and cAMP.
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